CPC
CVS icon

Congress Park Capital’s CVS Health CVS Stock Holding History

Congress Park Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,050
Closed -$241K – 117
2023
Q4 		$241K Sell
3,050
-1,975
-39% -$141K 0.12% 105
2023
Q3 		$351K Sell
5,025
-1,875
-27% -$133K 0.18% 89
2023
Q2 		$477K Buy
6,900
+800
+13% +$56.9K 0.24% 86
2023
Q1 		$453K Buy
6,100
+700
+13% +$58.7K 0.24% 84
2022
Q4 		$503K Sell
5,400
-425
-7% -$41K 0.3% 76
2022
Q3 		$556K Sell
5,825
-75
-1% -$7.42K 0.32% 68
2022
Q2 		$547K Hold
5,900
– – 0.33% 70
2022
Q1 		$597K Sell
5,900
-900
-13% -$94.5K 0.3% 73
2021
Q4 		$701K Hold
6,800
– – 0.35% 69
2021
Q3 		$577K Hold
6,800
– – 0.3% 72
2021
Q2 		$567K Sell
6,800
-3,350
-33% -$274K 0.28% 74
2021
Q1 		$764K Buy
10,150
+450
+5% +$32.8K 0.43% 58
2020
Q4 		$663K Sell
9,700
-1,853
-16% -$121K 0.39% 57
2020
Q3 		$675K Sell
11,553
-350
-3% -$21.8K 0.42% 52
2020
Q2 		$773K Buy
11,903
+1,300
+12% +$81.9K 0.59% 41
2020
Q1 		$629K Buy
10,603
+2,500
+31% +$167K 0.57% 39
2019
Q4 		$602K Hold
8,103
– – 0.44% 49
2019
Q3 		$511K Hold
8,103
– – 0.43% 53
2019
Q2 		$450K Buy
+8,103
New +$436K 0.36% 58
2018
Q4 		– Sell
-3,550
Closed -$279K – 85
2018
Q3 		$279K Hold
3,550
– – 0.25% 87
2018
Q2 		$228K Sell
3,550
-250
-7% -$16.5K 0.22% 91
2018
Q1 		$236K Sell
3,800
-15,090
-80% -$1.08M 0.24% 86
2017
Q4 		$1.37M Buy
+18,890
New +$1.37M 1.38% 23

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Congress Park Capital's CVS Position: Q1 2024 in Review

Congress Park Capital sold out of CVS Health (CVS) in Q1 2024, closing a stake of 3,050 shares — an estimated $241K sold.

Congress Park Capital first reported a position in CVS in Q4 2017 and held it in 23 quarters. The position peaked at $1.37M in Q4 2017. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Congress Park Capital reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Congress Park Capital sold 3,050 CVS Health shares in Q1 2024, an estimated $241K.
  • Congress Park Capital first reported a position in CVS Health in Q4 2017 and held it in 23 quarters.
  • Congress Park Capital's CVS Health position peaked at $1.37M in Q4 2017.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Congress Park Capital's 13F filing for Q1 2024, filed 16 Apr 2024.